-
Glenmark, Biocon units recall products in US
09 Apr 2025 15:08 GMT
Drug firms Glenmark and Biocon are recalling … and anxiety.
New Jersey-based Glenmark Pharmaceuticals Inc is recalling 8,160 … health outcomes is minimal.
Shares of Glenmark ended 4.35 per cent … the BSE on Wednesday.
Biocon shares, on the other hand, ended …
-
Global pharma shares plunge as Trump doubles down on tariff threat
09 Apr 2025 12:16 GMT
… manufacturing in the United States.
Shares of major U.S. drugmakers … Argenx, UCB, or Novo Nordisk.
Shares of AstraZeneca, GSK, Roche, Sanofi … by 0.6%.
IPCA Laboratories, Glenmark Pharma and Biocon were the …
-
Glenmark Pharma shares in focus as USFDA classifies recall of 39 drugs from US arm under Class-II
09 Apr 2025 10:23 GMT
Shares of Glenmark Pharmaceuticals are likely to … reversible adverse health consequences.
Glenmark, a major player in … . Its innovation arm, Ichnos Glenmark Innovation (IGI), is working … diseases.
In January 2024, Glenmark secured exclusive licensing rights …
-
Glenmark recalls 39 drugs in US under Class-II category, cites expiry as key reason
09 Apr 2025 10:23 GMT
Shares of Glenmark Pharmaceuticals remained under pressure on … As of 2:40 PM, Glenmark shares were down 4.57% on … . Its innovation subsidiary, Ichnos Glenmark Innovation (IGI), is actively … commercial launches targeted for FY26. Glenmark also projects a $600– …
-
Biocon shares drop over 6% today; Board approves Rs 600 crore fundraise via commercial papers
07 Apr 2025 10:48 GMT
Shares of biotechnology major Biocon Ltd … .
Top pharma losers: Biocon, IPCA, Glenmark, Divi’s, Dr Reddy’s … .67% to ₹1,333.90 Glenmark slipped 3.56% to ₹1 …
-
Glenmark Pharmaceuticals shares fall over 4% after Trump’s pharma tariff warning
04 Apr 2025 05:12 GMT
Shares of Glenmark Pharmaceuticals Ltd fell 4.35% to … a cautiously optimistic stance on Glenmark, stating the company has moderate … However, the brokerage flagged that Glenmark’s Monroe manufacturing facility in … up to 5–10% of Glenmark’s revenues by FY27.
…
-
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
01 Apr 2025 05:36 GMT
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Vancomycin … /vial (Single-dose vial). Glenmark's Vancomycin Hydrochloride for … our institutional portfolio."
Shares of Glenmark Pharmaceuticals Limited was last trading in …
-
Gland Pharma, other pharma stocks fall up to 6% as Trump signals major tariff on imports
09 Apr 2025 07:25 GMT
Pharma shares fell up to 6% on … ; tariff on pharmaceutical imports.
The shares of Gland Pharma experienced the … 4.2% respectively.
Glenmark Pharmaceuticals, Lupin and Biocon shares were down by a …
-
Stock market update: Nifty Pharma index advances 1.91%
08 Apr 2025 17:47 GMT
… a positive note on Tuesday.
Shares of Ajanta Pharma Ltd.(up … 1.51 per cent) and Glenmark Pharmaceuticals Ltd.(down 0.1 per … 1 closed in the red.
Shares of Vodafone Idea, YES Bank … among the most traded shares on the NSE.
Shares of Mangalore Chem …
-
Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2%
20 Mar 2025 17:34 GMT
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final … the U.S. by Glenmark Therapeutics Inc., USA.
According … for our customers."
Shares of Glenmark Pharmaceuticals Limited was last trading … The total number of shares traded during the day …
About
© 1995-2025